Literature DB >> 6508238

The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study.

A R Wintzen, H de Jonge, E A Loeliger, G T Bots.   

Abstract

In a retrospective study of 166 patients, all admitted to the University Hospital, Leiden, The Netherlands, between January 1, 1970 and December 31, 1979, we estimated the relative risk of intracerebral hemorrhage from oral anticoagulant therapy. The risk was more than ten times higher for patients over 50 years of age than for similarly aged untreated individuals in the general population. Within this age group the risk was influenced by neither age nor sex. Hypertension, present in 80% of the patients, was the most important predisposing condition; the risk of bleeding rose with increasing intensity of anticoagulation. There was no substantial difference in clinical condition at onset, rate of progression, mortality, or degree of recovery between patients with anticoagulant-associated hemorrhage and those with spontaneous intracranial hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6508238     DOI: 10.1002/ana.410160505

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

1.  Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage.

Authors:  R Fogelholm; K Eskola; T Kiminkinen; I Kunnamo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.

Authors:  Sachin J Shah; Daniel E Singer; Margaret C Fang; Kristi Reynolds; Alan S Go; Mark H Eckman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-11-11

Review 3.  Anticoagulant drugs in the elderly: the risks usually outweight the benefits.

Authors:  P J Scott
Journal:  BMJ       Date:  1988-11-12

4.  Intracerebral hemorrhage: clinical overview and pathophysiologic concepts.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Transl Stroke Res       Date:  2012-04-21       Impact factor: 6.829

5.  Efficacy of long-term anticoagulant treatment in subgroups of patients after myocardial infarction.

Authors:  P F van Bergen; J W Deckers; J J Jonker; R T van Domburg; A J Azar; A Hofman
Journal:  Br Heart J       Date:  1995-08

Review 6.  Clinical evaluation and management of transient ischemic attacks.

Authors:  J F Rothrock
Journal:  West J Med       Date:  1987-04

7.  [Intracranial and intraspinal hemorrhages in treatment with coumarin derivatives. Catamnesis of 63 cases between 1978 and 1986].

Authors:  D Moskopp; F Brassel; F Ries
Journal:  Klin Wochenschr       Date:  1987-08-17

8.  Current treatment options for intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

Review 9.  A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks.

Authors:  Beata Bajorek
Journal:  Ther Adv Drug Saf       Date:  2011-04

Review 10.  Clinical review: Critical care management of spontaneous intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Crit Care       Date:  2008-12-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.